Gene Expression Market Is Expected To Reach USD 11.3 Billion By 2025

Global Gene Expression Market is expected to reach USD 11.3 billion by 2025, according to a new report by Grand View Research, Inc. Globally rising demand for targeted molecular therapeutics coupled with rising adoption of precision medicine is anticipated to fuel market growth.

Understanding gene expression under different conditions as well as the effects it has on different metabolic activities has opened various vistas for the development of a novel generation of molecular therapeutics. Search for methods to manipulate the way a coding DNA is expressed as a cure to different conditions arising due to abnormally expressed genes is expected to drive market.

Target expression analysis and single cell analysis using low- to mid- plex techniques to identify smallest differences and correlations in gene expression. Novel products focusing on with improved efficiency and reliability are launched for smaller samples. Increased interest stem cell and gene therapy are projected to propel revenue generation for the market.

Emerging NGS technologies coupled with their drastically declining prices are anticipated to boost adoption of gene expression techniques. Furthermore, government support through initiatives such as Precision Medicine Initiative would encourage private investments in the sector leading to market growth.

Drug discovery and development was estimated with largest share owing to higher adoption in drug response testing for severs and complicated diseases such as all types of cancer, tuberculosis, cardiac conditions and rare genetic disorders. However, clinical diagnostic application is projected with fastest growth owing to rising demand for rapid and accurate diagnosis of complex diseases coupled with their higher incidence.

Rising demand for precision medicine, higher prevalence of genetic disorders, and rapid advances in biotechnology is attributive to largest contribution to revenue by North America. Owing to the presence of countries, witnessing rapid economic developments and demand for better health care solutions Asia Pacific is anticipated to witness the fastest growth.

Full Research Report on Global Gene Expression Market Analysis: http://www.grandviewresearch.com/industry-analysis/gene-expression-analysis-market

Further key findings from the report suggest:

• RNA expression dominated the market with respect to analysis technique as the increased interest of researchers has been observed to have been directed to understanding RNA activity to better understand its effects on diseases
• As there are a high number of products available for low to mid-plexing of gene expression, the segment was observed to have accounted for the higher share
• Rising focus on higher accuracy is anticipated to drive growth of high-plex techniques.
• Moreover, increased focus on cancer genomic is anticipated to bolster growth
• Introduction of improved data analytics & interpretation with high turnaround efficiency coupled with increase in incidences of target diseases are vital factor influencing R&D.
• Substantial adoption of gene expression techniques the U.S. can be attributed for the largest share of North American market.
• Asia Pacific is anticipated to witness a high growth rate due to the presence of initiatives by key market participants to enhance presence in these emerging economies due to the presence of untapped potential
• Key players contributing in this market are Qiagen, Quest Diagnostics Incorporated, Illumina, Bio-Rad Laboratories, Oxford Gene Technology, TAKARA,Biocartis Group NV, MYRIAD GENETICS, INC.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Gene Expression Analysis Market on the basis of process, product, capacity, technique, application, and region:

Process Outlook (Revenue, USD Million; 2014 - 2025)

• Sample Collection
• Purification
• cDNA synthesis & conversion
• PCR Analysis
• Data analysis & interpretation

Product Outlook (Revenue, USD Million; 2014 - 2025)

• Kits & Reagents
• DNA Chips
• Others

Capacity Outlook (Revenue, USD Million; 2014 - 2025)

• Low- to Mid- Plex
• High-Plex

Technique Category Outlook (Revenue, USD Million; 2014 - 2025)

• RNA Expression
• Northern Blotting
• DNA Microarrays
• PCR Techniques
• RNA-Seq
• Promoter Analysis
• In vitro Transcription/Nuclear Run-On Assays
• Gel Shift Assays
• Chromatin Immunoprecipitation (ChIP)
• Protein Expression & Posttranslational Modification Analysis
• Western Blotting
• 2-D Gel Electrophoresis
• Immunoassays
• Mass Spectrometry

Application Outlook (Revenue, USD Million; 2014 - 2025)

• Drug Discovery & Development
• Clinical Diagnostics
• Biotechnology & Microbiology
• Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East and Africa (MEA)
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-gene-expression-analysis-market                    

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Antimicrobial Coatings Market Demand was 372.9 Kilotons In 2015 And Is Expected To Exceed 1 Million Tons By 2025

Global Antimicrobial Coatings Market is expected to reach USD 8.43 billion by 2025, according to a new report by Grand View Research, Inc. Increasing concern among professional industry manufactures about cleaning and to prevent buildings against the growth of bacteria, mold and fungi are expected to drive the overall market growth.

Recent food poisoning outbreaks coupled with high rates of hospital-acquired infections had heightened the awareness among people. Nowadays, people mainly insist on safe and healthy products by offering more for such goods and services.

Silver based biocides are widely used in medical grade applications owing to its excellent antimicrobial properties. Recently, a new U.S. based is othiazolin-based biocide, n-butyl-1,2-benzisothiazolin-3-one is also used as an antimicrobial agent to prevent the spread of germs. 

Moreover, rising demand for implantable medical devices and increasing burden of cardiovascular diseases is expected to aid the overall market demand over the next eight years.

However, stringent regulations issued by both U.S. and the European Union are anticipated to critically affect the industry over the next eight years. Companies’ products have to be approved and registered with EPA for their specific requirement in which they are used. Recently, manufacturers incorporated antimicrobial agents in the bulk material, which is considered a viable alternative for its application in antibiotics.

Full Research Report on Global Antimicrobial Coatings Market Analysis:
http://www.grandviewresearch.com/industry-analysis/antimicrobial-coatings-market

Further key findings from the report suggest:

• The global antimicrobial coatings market demand was 372.9 kilotons in 2015 and is expected to exceed 1 million tons by 2025, growing at a CAGR of 10.4% from 2016 to 2025
• Mold remediation is expected to witness the highest CAGR of 11.1% over the forecast period. The cost involved in remediating a mold-infested building can be staggering, especially when the building has inferior coatings.
• These coatings provide long-term protection against growth and spread of bacteria, mold, and fungi. After Shock is an antimicrobial coating, registered under EPA which is designed to kill mildew and residual mold.
• Air conditioning and ventilation segment were accounted for over 25% of the overall volume in 2015. These products help to deter the growth of micro-organisms in heating, ventilation and air conditioning systems. AgION coated materials inhibit the growth of different microbes.
• The industry is characterized by the presence of multinational companies which holds the major chunk of the total revenue. Industry participants mainly include Diamond Vogel, Dow Microbial Control, AkzoNobel N.V and Sherwin Williams.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/paints-coatings-and-printing-inks

Grand View Research has segmented the Global Antimicrobial Coatings Market on the basis of product, application and region:

Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Antimicrobial powder coatings
• Silver
• Copper
• Other
• Surface modifications and coatings
• E. Coli
• Listeria
• Pseudomonas
• Others

Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Sanitary facilities and kitchen
• Air conditioning and ventilation systems
• Food processing and packaging
• Antimicrobial textile
• Mold remediation
• Construction
• Other applications

Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Europe
• Germany
• UK
• France
• Asia Pacific
• China
• India
• Central & South America
• Middle East & Africa

View Press Release Of This Report by Grand View Research: 

http://www.grandviewresearch.com/press-release/global-antimicrobial-coatings-market                           

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Cancer Diagnostics Market Is Projected To Grow At A CAGR Of 7.2% During Forecast Period 2014-2025

Global Cancer Diagnostics Market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth. In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility of their products. For instance, Illumina, Inc. launched a new venture named GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than $100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Full Research Report on Global Cancer Diagnostics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/cancer-diagnostics-market

Further Key Findings from the Study Suggest:

• Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of the imaging systems space. Thus, the segment is expected to grow at the fastest CAGR at over 8.0% during the forecast period.
• The breast cancer segment, among other application segments, accounted for the largest share due to the high incidence rate of breast cancer triggering the need for its early diagnosis.
• In 2016, North America dominated the global space with the largest revenue share of more than 41%. Focused research efforts in oncology for the development of early tumor detection tools coupled with grants from government healthcare agencies are contributing to a strong medical ecosystem to fight cancer in this region.
• Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing patient pool in India, China, and Japan; due to the support in diagnostic process at comparatively lower prices; and a favorable regulatory framework are some of the factors boosting the market growth in this region.
• Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd and Siemens Healthcare GmbH. Other prominent players operating in the market include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; .and Hologic, Inc.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the Global Cancer Diagnostics Market by screening type, application, and region:

Cancer Diagnostics Screening Type Outlook (Revenue, USD Billion; 2014 - 2025)

• Laboratory Tests
• Genetic Tests
• Imaging
• Endoscopy
• Biopsy
• Others (barium enema)

Cancer Diagnostics Application Outlook (Revenue, USD Billion; 2014 - 2025)

• Breast Cancer
• Colorectal Cancer
• Cervical Cancer
• Lung Cancer
• Prostate Cancer
• Skin Cancer
• Blood Cancer
• Kidney Cancer
• Liver Cancer
• Pancreatic Cancer
• Ovarian Cancer
• Others

Cancer Diagnostics Regional Outlook (Revenue, USD Billion; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-cancer-diagnostics-market                          

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Infectious Disease Therapeutics Industry Outlook By Executive Summary, Market Dynamics, Market Size And Growth Prospects 2014-2025

Global Top 6 Infectious Disease Therapeutics Market is expected to reach USD 86.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing number of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis cases globally.

Government and private organizations are investing heavily in the healthcare sector to prevent, diagnose, and treat infectious diseases; rising investments for development of new drugs to treat infectious diseases, and increasing number of initiatives for creating awareness about these conditions are expected to boost the market during the forecast period. Furthermore, increasing number of patent expirations and entry of generic drugs in the market are expected to increase the demand for infectious disease therapeutics due to their low prices.

In addition, availability of reimbursement for diagnosis & treatment of these infections and free distribution of drugs by manufacturers in regions with high incidence of these diseases are factors further expected to propel the market growth. However, low penetration rate of anti-infective and availability of large number of counterfeit drugs are expected to restraint the market growth during the forecast period.

North American market held the largest share in 2016. Presence of large number of manufacturers, favorable reimbursement scenario, and increasing healthcare expenditure are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. High prevalence of infectious diseases; improving economic conditions in Asian countries, rising government initiatives to increase the adoption of treatments for infectious diseases, and rising funding activities are factors that can be attributed for the highest growth rate of this region during the forecast period.

Full Research Report On Global Infectious Disease Therapeutics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/infectious-disease-therapeutics-market

Further Key Findings From the Report Suggest:

• The HIV therapeutics segment held the largest revenue share in 2016 due to high number of HIV cases globally
• North America dominated the global market owing to the strong reimbursement framework coupled with high adoption rate of treatments for infectious diseases

• The HPV therapeutics segment is estimated to grow at the highest rate during the forecast period
• Some of the key players areNovartis AG, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals, Inc., and Boehringer Ingelheim GmbH

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Top 6 Infectious Disease Therapeutics Market on the basis of disease type and region:

Disease Type Outlook (Revenue, USD Million, 2014 - 2025)

• HIV
• Emtriva
• Aptivus
• Isentress
• Lexiva/Telzir
• Selzentry
• Tivicay 
• Atripla
• Complera
• Genvoya
• Odefsey
• Stribild
• Truvada
• Triumeq
• Descovy
• Vitekta
• Others
• Influenza
• Relenza
• Tamiflu 
• Rapivab 
• Others
• TB
• Sirturo
• Others
• Malaria
• Coartem
• Others
• HPV
• Hepatitis

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-infectious-disease-therapeutics-market                         

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Wireless Mesh Network (WMN) Industry Outlook By Executive Summary, Market Variables, Trends And Scope 2014-2025

Global Wireless Mesh Network (WMN) Market is expected to reach USD 11.13 billion by 2025, according to a new report by Grand View Research, Inc. The increasing adoption of the wireless communication medium and the usage of artificial intelligence and IoT has been a major factor driving the global market growth. In addition, the growing opportunities in oil & gas industries and the development of smart cities and infrastructure have led to the increased adoption of WMN. 

The wireless mesh network enables citywide public Wi-Fi that in turn improves the delivery of urban services. It is forecasted that wireless devices would account for two-thirds of the IP traffic and almost all households would have broadband services. In cities, WMN could solve the congestion problem with traffic management solutions where traffic data is analyzed and pre-emptive solutions are provided for free-flowing traffic.

The oil & gas segment would be the fastest-growing segment of end-use applications over the forecast period. The education segment would be the lowest-developing segment in wireless mesh network market over the forecast period at a CAGR of 7.2%.

The video surveillance segment is expected to observe the fastest growth over the next eight years with an estimated CAGR of around 10.1%. Wireless mesh network improves coverage, structural flexibility, and multi-hop high-speed short distance transmission capability of video surveillance systems.In addition, it is estimated that the Asia Pacific region will witness an increasing usage of wireless mesh network.

Full Research Report on Global Wireless Mesh Network (WMN) Market Analysis:
http://www.grandviewresearch.com/industry-analysis/wireless-mesh-network-wmn-market

Further key findings from the report suggest:

• The global demand for WMN exceeded USD 5,281.6 million in 2016 and the market is expected to grow at a CAGR of 8.8% over the forecast period.
• The 2.4 GHz band segment dominated the market in 2016 and is estimated to generate revenue over USD 4.44 billion by 2025.
• The disaster management and rescue operations segment was valued at USD 1,372.9 million in 2016 and is anticipated to witness high growth over the next eight years.
• The smart cities & smart warehouses segment market in WMN was USD 1,087.3 million in 2016 and is estimated to reach USD 2,561.6 million by 2025.
• The Asia Pacific regional market is projected to witness substantial growth over the next eight years owing to the increasing number of smart city projects. The regional market and is expected to attain USD 2,907.1 million by 2025, growing at a CAGR of 7.1%.
• Key players including Cisco Systems, Inc., Aruba Networks Inc., Ruckus Wireless, Inc., and Firetide, Inc. dominated the global WMN market in 2016.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/communications-infrastructure-systems-and-software

Grand View Research has segmented the Wireless Mesh Network (WMN) market on the basis of radio frequency, application, end use, and region:

Radio Frequency Outlook (Frequency, Hertz; Revenue, USD Million; 2014 - 2025)

• Sub 1 GHz band
• 2.4 GHz band
• 4.9 GHz band
• 5 GHZ band

Application Outlook (Revenue, USD Million; 2014 - 2025)

• Home Networking
• Video Surveillance
• Disaster Management and Rescue Operations
• Medical Device Connectivity
• Traffic Management

End-use Outlook (Revenue, USD Million; 2014 - 2025)

• Education
• Government
• HealthCare
• Hospitality
• Mining
• Oil & Gas
• Transportation & Logistics
• Smart Cities and Smart Warehouses
• Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Middle East & Africa 

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-wireless-mesh-network-wmn-market                        

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Prefilled Syringes Market Size Is Anticipated To Reach USD 22.5 Billion By 2025

Global Prefilled Syringes Market size is expected to reach USD 22.5 Billion by 2025, according to a new study by Grand View Research, Inc. Key factors driving the market expansion include technological advancements in auto-injectors and growing usage of prefilled syringes owing to its reduced prices per dose.

Prefilled injecting devices are rapidly replacing traditional syringe-vial combinations due to certain associated advantages such as increased patient safety and convenience offered to healthcare practitioners in dose preparation. Growing trend of self-injecting devices adopted for the management of chronic diseases, such as diabetes and rheumatoid arthritis, are expected to boost the growth of auto injectors and pen injectors during the forecast period. Growing prevalence of these diseases and introduction of advanced devices with Wi-Fi and Bluetooth connectivity that facilitate effective management of patient health records are factors expected to boost the usage of such devices.

Application of prefilled injectors is currently limited to emergency rooms in hospitals and for the treatment of certain chronic diseases. These injection devices are considered ideal containers for vaccines and biotech drugs, which otherwise tend to become unstable and react with the material of the container that result in altered drug potency. Growing preference toward biotechnology drugs and the emerging biotech space presenting greater opportunities are expected to have a positive impact on the growth of the prefilled syringes market during the forecast period. 

Full Research Report on Global Prefilled Syringes Market Analysis:
http://www.grandviewresearch.com/industry-analysis/pre-filled-syringes-market

Further key findings from the study suggest:

• The use of glass syringes to be high owing to their increasing preference amongst healthcare professionals; this is attributable to their ease of use and the low risk posed by these devices at the time of injection.
• However, the plastic segmentis rapidly replacing the former with the introduction of advanced plastic materials, such as polypropylene and crystal clear polymer, which are biocompatible as glass.
• Europe dominated the prefilled syringes space in 2015. High adoption of patient safety measures and presence of large number of market players are the factors responsible for the dominance of the region.
• North America region is expected to show the fastest growth rate during the forecast period due to rapid adoption of prefilled syringes in this region.
• The market is presently dominated by few key participants such as Gerresheimer AG, Haselmeier AG, Nipro Medical Corporation, Unilife Corporation,Owen Mumford, SCHOTT, Datwyler Pharma Packaging, and Becton, Dickinson and Company.
• The syringe manufacturing market is consolidated; however, various new players are bringing innovative technologies to this sphere,which can be used for the manufacturing of auto-injectors.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Prefilled Syringes Market by type, material, application, distribution channel, and region:

Prefilled Syringes Type Outlook (Revenue, USD Million; 2014 - 2025)

• Disposable Prefilled Syringes
• Reusable Prefilled Syringes

Prefilled Syringes Material Outlook (Revenue, USD Million; 2014 - 2025)

• Glass Prefilled Syringes
• Plastic Prefilled Syringes

Prefilled Syringes Application Outlook (Revenue, USD Million; 2014 - 2025)

• Anaphylaxis
• Rheumatoid Arthritis
• Diabetes
• Others (Vaccines and other biotech drugs)

Prefilled Syringes Distribution Channel Outlook (Revenue, USD Million; 2014 - 2025)

• Hospitals
• Mail Order Pharmacies
• Ambulatory Surgery Centers

Prefilled Syringes Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-prefilled-syringes-market                       

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Cellular IoT Market Is Expected To Reach USD 9.65 Billion By 2025

Global Cellular IoT Market is expected to reach USD 9.65 billion by 2025, according to a new study by Grand View Research, Inc. The hype around Internet of Things (IoT) and its tremendous potential to revolutionize machine-to-machine and machine-to-human communications has reached its peak, owing to which numerous technology vendors are prodding different variants of emerging technologies to capitalize on this opportunity. With increased pervasiveness of cellular connectivity and the ready availability of its extensive networks, mobile broadband is anticipated to gain unprecedented significance in IoT.

An important aspect of the growth of cellular IoT is its ability to leverage mobility and range as compared to other IoT access methods, which can be the major differentiating factor over its contemporary service delivery techniques. In addition, cellular networks operate on the existing network infrastructure and offer reliable and quality services with assured security, which would play a vital role in their adoption in both industrial and consumer applications.

While cellular IoT primarily operates on the LTE technology, the emergence of other Low Power Wide Area Networks (LPWAN), such as LoRA and SigFox, and comparatively higher costs of cellular modules may hinder the market growth in the next couple of years. The role played by emerging technologies such as NarrowBand-IoT and NarrowBand-LTE-M will be instrumental in the hustle for gaining M2M market share. These technologies are specifically designed for IoT applications and are on the verge of commercialization with numerous pilot projects being launched in different parts of the world.

Cellular IoT offers numerous advantages such as broader coverage, deep indoor penetration, and smaller module size, owing to which it is largely preferred in high-density deployments. This is also expected to aid in the increased adoption of the technology over the next decade. Furthermore, cellular technologies, especially LTE, are supported and backed by a consortium of established industry players and various organizations such as 3^rd Generation Partnership Project (3GPP) and Global System for Mobile Association (GSMA), which is expected to boost the market growth in the coming years.

Full Research Report on Global Cellular IoT Market Analysis: http://www.grandviewresearch.com/industry-analysis/cellular-iot-market

Further key findings from the study suggest:

• North America is expected to maintain its dominant position in the global market owing to a greater penetration of next-generation LTE technologies, especially in the U.S.
• 2G holds the largest market share in terms of revenue generated; however, it is expected to gradually lose its share to emerging technologies, such as 4G, LTE-M, and NB-IoT. An interesting factor about the competing technologies, is the way in which these technologies operate in relation to each other (LTE-M vs NB-LTE-M vs NB-IoT) and whether they act as complementary or rival technologies in IoT
• Standard bodies, including 3GPP, are actively promoting the usage of cellular IoT technology and network transformation in broadband connectivity, which is expected to drive market growth and standardization over the forecast period.
• Remote monitoring, cloud connectivity, predictive maintenance, remote operation, and remote maintenance are some of the major applications being commercialized in different end-use industries.
• Numerous applications of cellular IoT are anticipated to be the most important growth driver for the market with a phenomenal increase in device shipments over the forecast period.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the Global Cellular Iot Market based on components, types, end uses, and regions:

Component Scope (Revenue, USD Million; 2014 - 2025)

• Hardware
• Software

·         Device Management

·         Signal Processing

Type Scope (Revenue, USD Million; 2014 - 2025)

• 2G
• 3G
• 4G
• LTE-M
• NB-LTE-M
• NB-IoT
• 5G

End-use Scope (Revenue, USD Million; 2014 - 2025)

• Agriculture
• Automotive & Transportation
• Consumer Electronics
• Energy
• Environment Monitoring
• Healthcare
• Retail
• Smart Cities
• Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Middle East & Africa (MEA)

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-cellular-internet-of-thing-iot-market                      

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com